One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population.

Diabetes Obes Metab · 2026 · PMC12803620 · PMID 41189335

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Prior antifungal use showed a trend, increasing across groups from adherent to intolerant. 3.5 SGLT2i : Clinical Characteristics Associated with Poor Adherence Full univariable and multivariable models are provided in Table S3 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.